Introduction
Current world-wide interest in immunity against cancer in man is sustained by rapidly expanding laboratory information on particular immunological reactions in a variety of tumours (Hellstrom et al., 1971a) . Patients with malignant melanoma (British Medical Jfournal, 1970 ), Burkitt's lymphoma (Klein, 1971) , and neuroblastoma (Bill, 1969) (Lewis et al., 1969; Ikonopisov et al., 1970; Currie et al., 1971) . There were several differences in technical detail which are described.
TUMOURS, LYMPHOCYTES, AND SERA
Nine patients with squamous cell carcinoma of skin were studied, selected only in so far as their resected tumours yielded enough cells for testing. Histopathological confirmation of diagnoses was obtained on formalin-fixed paraffin sections stained with haematoxylin and eosin, and, as necessary, by phosphotungstic acid haematoxylin; methyl-green/pyronin staining was used to assess plasma cell reactions.
Cell suspensions were made from specimens transported in culture medium 199 
IMMUNOFLUORESCENCE TESTS
These were carried out with appropriate controls and serum absorptions by general procedures described elsewhere (Nairn, 1969) . Membrane staining of viable cancer cells in suspension was conducted with the aid of an apparatus permitting partial mechanization and the simultaneous study of up to 40 serum samples (Nairn et al., 1971 , which gives optimum immunofluorescence .
The centrifuged cell deposit in a residual drop of the final buffer was mounted with a drop of glycerol (A.R. grade) on a microscope slide using a 2-cm circular coverglass to provide a convenient area for microscopical examination. It is important to use the minimum volume of suspension fluid to fill the area of the coverglass which is sealed with a ring of nail varnish; this permits examination of a "monolayer" of cells by highpower and glycerol-immersion objectives. Examination was by darkground ultraviolet fluorescence microscopy with a colourless barrier filter.
Cytoplasmic staining was studied on cell films. For these, cell suspensions were washed as for membrane immunofluorescence but with 0-50o fetal calf serum in the final washing solution to assist adhesion of the films to microscope slides. fetal calf serum and then generally they were added to the tumour cells when the culture was first set up, at twice the concentration of the original tumour inoculum-that is, 2 x 106 lymphocytes in 1 ml of 199 plus 100/ fetal calf serum were added to 106 of the cells from the tumour in 1 ml of the same medium; thereafter 0 4 ml of human group AB serum rich in complement was added. We do not know whether the presence of complement is essential for this lymphocytotoxicity test but on several occasions have had evidence of enhancement of reactivity by it. The mixture, which contained about 2-5 lymphocytes per tumour cell-that is, at least 5 per viable tumour cell-was transferred to three separate culture chambers each holding about 0-7 ml and incubated with repeated examinations over seven days. In Case 1 a second test was performed in which addition of the lymphocytes was delayed until the tumour cell culture had been established for five days. The addition was made by removing the microscope slide closing one side of the chamber, leaving viable tumour cells attached to the coverglass closure. The original culture fluid was replaced by the lymphocyte suspension in fresh medium and the chamber re-closed by a second coverglass which became the bottom of the preparation when inverted. In this experiment the ratio of lymphocytes to tumour cells was estimated to be not less than 10:1. Such a chamber with fresh culture medium and coverglass closures top and bottom is more satisfactory optically for phase-contrast time-lapse cinephotomicrography than the standard preparations. (Nairn, 1969) both for the immunofluorescence and the serum cytotoxicity tests. Examination of reactivity of tumour cells with positive sera before and after absorptions, with normal sera or control sera from other cancer patients, and with lymphocytes from other individuals provided one group of specificity tests. Other tests were made on the serum and lymphocytes with the patient's normal epidermal cells and fibroblasts, and with other tumours, including a squamous cell carcinoma from another patient. In addition, serum cytotoxicity was studied with human blood group AB serum complement before and after inactivation.
Monospecific antihuman-globulin fluorescein conjugates with activity against IgG, IgM, and IgA respectively were used to examine the immunoglobulin class responsible for the cytoplasmic immunofluorescent staining in Case 1.
All the patients' sera were examined by immunofluorescence for possible autoantibody activity against nuclei, mitochondria, smooth muscle, and other normal tissue elements.
Results
Of the nine cases, eight showed at least one type of immunological reactivity between their serum or peripheral blood lymphocytes and their own tumour (Table I) ; more than one response was observed in four cases. There was no example of globulin binding to the tumour in vivo in any of the patients. (Table II) .-The patient's serum unabsorbed gave strong cytoplasmic staining of the tumour cell films (Special Plate, Fig. 4 ). With the monospecific antiglobulin conjugates the reactivity was found to be due predominantly to IgG. The absorptions, which also included homogenate of a maligant melanoma here, had much the same selective effects as in the membrane staining: only the patient's own tumour had the capacity to neutralize all serum reactivity. Again the second serum sample gave weaker staining, and neither sample stained the patient's epidermal cells or Case 2 squamous cell carcinoma. Fig. 5 ). In the presence of the patient's first serum sample, plus either active or inactivated complement, there was virtually total cytodestruction over the course of five days. The second serum sample gave much the same result except that total destruction occurred only in the cultures to which active complement had been added; with the inactivated complement, destruction was severe but not complete. Complement-dependence of the cytotoxicity thus seems only partial, but this could well be attributable to in-vitro production of complement by the lymphocytes inevitably present in a tumour cell suspension prepared from a carcinoma so heavily infiltrated by lymphoid cells as in Case 1. Absorption of the patient's serum with homogenates of (a) her own skin had no effect on cytotoxicity, (b) normal human liver reduced cytotoxicity by about 50%, and (c) her own tumour homogenate abolished almost all reactivity. The second serum sample was tested against the tumour cells of Case 2, and also against cultures of a malignant melanoma and a colonic carcinoma: there was no evidence of cytotoxicity.
Lymphocytotoxicity.-Whether the patient's lymphocytes were added to the tumour cells at the time the cultures were first set up or five days after, some, within an hour or two, became firmly attached to many of the tumour cells, often no more than one or two per cell (Special Plate, Fig. 6 ). Progressively over the course of five days such a tumour cell was totally destroyed. The sequence of events in this process could be followed in most detail by time-lapse cinephotomicrography (Special Plate, Fig. 7 ).
In the single microscope field studied at. any one time by this technique, lymphocytes could be seen moving passively in the medium until one, presumably specifically immunoreactive, encountered a tumour cell, to which it became attached. Sometimes actual attachment required several minutes during which the lymphocyte rebounded a few times from the tumour cell and edged unsteadily along its surface, apparently because of superficial cytoplasmic agitation with pseudopod formation in the target region. This local agitation continued for about an hour after firm attachment, which could be recognized by the now synchronous movements in the field of both lymphocyte and tumour cell. The lymphocyte sometimes looked actively mobile and in one instance of attack by another lymphocyte on an already damaged cell (Fig. 7 H ) microscopic processes could be detected near the limit of visibility between the lymphocyte and target area.
Within some eight hours of the initial lymphocyte attachment, the tumour cell started to become more spherical, and was usually quite spherical by about 12 hours. At this stage the nuclear definition was diminished and altogether lost within 24 hours, and at the same time peripheral cytoplasmic blebs appeared and became increasingly conspicuous for up to five days. The bleb formation seemed to be responsible for the shedding into the medium of numerous spherical fine membranous 5-8-nm vesicles from the dying tumour cells on about the second and third days. Finally, the vesicles ceased to appear, a day or two later movement of the cytoplasmic blebs stopped, and the tumour cell became an inert amorphous spherical mass with a dull phase-contrast image, but did not disintegrate even after eight days' total observation following the addition of the lymphocytes.
The lymphocytes did not show any of these effects against cultured fibroblasts of the patient or a suspension in culture of her normal epidermal cells (Special Plate, Fig. 8 cases of squamous cell carcinoma, and none with sera from one case of basal cell carcinoma and three cases of malignant melanoma; the autologous reaction was also negative. The autologous reaction was positive for the cytoplasmic staining, which showed positive cross-reactivity with two of the four samples of serum from Case 3, but not with the sera of Case 1 or any other of the 16 serum samples mentioned above. Interestingly, the two cross-reacting sera were later samples obtained two and six weeks after many of the multiple skin tumours of Case 3 had been resected.
In the cytotoxicity tests, nine serum samples from each of the nine squamous cell carcinoma cases were tested: eight were negative, including the autologous reaction. Weak crossreactivity was observed with a serum sample from Case 3. Lymphocytotoxicity was also negative with the autologous lymphocytes and those from Cases 1, 4, and 8, one melanoma, and one colonic carcinoma patient.
Discussion
The data show that immunological reactivity by blood serum and/or lymphocytes is common in patients with squamous cell carcinoma of skin. In particular, lymphocytotoxicity was most often positive of the reactions tested. There can be little doubt that this is likely to be the response most significant clinically. Serum antibodies, even if reactive, as in Cases 1, 3, and 4, with tumour cell surface as demonstrated by cytotoxicity and membrane immunofluorescence tests, will probably have only limited access to solid tumour tissue. If not cytotoxic in vivo, as, for example, when complement is deficient, they could perhaps block the effects of immune lymphocytes (cf. Hellstrom et al., 1971b) . It is noteworthy that Cases 1 and 4, with the most intense local infiltration of tumour by lymphoid cells, also showed the clearest positive in-vitro tests for immunological reactivity.
The failure of the infiltrating lymphoid cells within this carcinoma to destroy cultivated tumour cells or even to prevent cultured tumour growth suggests a local immunological paralysis or other lymphocytic incompetence not shared by some peripheral blood lymphocytes, which were demonstrably cytotoxic. Such non-reactivity of lymphoid tissue in the immediate drainage area of a tumour has also been observed in experimental studies (Alexander et al., 1969) and could explain the thriving of metastatic deposits in regional lymph nodes. Its association with more general lymphocyte reactivity, not necessarily overt, might account for the provoking of immune responsiveness in patients who are otherwise non-reactive (Ikonopisov et al., 1970; Currie et al., 1971 to contribute to local immunological and inflammatory events but not to any specific rejection process of viable tumour cells. One speculative explanation of the possible relationship between such surface-and cytoplasmic-reactive immunity is given in (Fig. 10 ).
Immunological specificity and cross-reactivity were studied mainly in Case 1, in which it was found that the patient's lymphocytes reacted against her tumour cells but not her normal fibroblasts or skin, nor against four other tumours, including two squamous cell carcinomas. The patient's serum reactivity by whatever test was partly limited to her own tumour and could not be abolished except by absorption with her tumour. Absorption by two other squamous cell carcinomas, a melanoma, normal skin, including the patient's own, and normal human liver each reduced immunofluorescent staining, both membrane and cytoplasmic, incompletely and by about the same degree. Serum cytotoxicity, though not diminished by absorption with the patient's skin homogenate, was partially reduced by the liver homogenate absorption. This suggests that the antitumour activity in the serum included antibodies weakly reactive with components common to other human tissues, though no particular autoantibodies to normal tissue were in fact detected.
The residual antitumour activity after serum absorption could reasonably be regarded as largely, if not totally, tumourspecific and not cross-reactive with at least two other squamous cell carcinomas. Such partial cross-reactivity, if applicable to other tumour immunity situations, may reconcile the discrepant reports on melanoma discussed by Hellstrom et al. (1971a) . It might be identifiable only in seropositive cases with adequate material for comprehensive serum absorption testing.
The cross-reactivity tests carried out against the tumour cells of Case 2 were all negative except for Case 3, which was seropositive by immunofluorescence and cytotoxicity.
The lymphoid infiltration seen histologically in the biopsy specimen of Case 1 looked like a reaction to the proliferating tumour cells themselves and there was no sign of any extraneous cause for it. It seems reasonable to suppose that such lymphoid infiltration in carcinomas of skin is a host attempt at immunological rejection. Almost invariably by the time the tumour is clinically detectable such rejection must be ineffective, the lesion having outpaced the defences; this might be partly due to the lack of local lymphoid reactivity against the tumour, as in Case 1. It may be speculated that the best means of reversing this situation would be extirpation of sufficient tumour to permit recovery from the regional immunological insufficiency and opportunity for the reactive lymphocytes of the body to deal with a small enough number of residual cells to assure their elimination. The favourable immediate outcome of the local x-ray therapy in Case 1, in which the prognosis looked initially grave, might be attributable to an unusually vigorous systemic antitumour immunoreactivity. 
